Sub-Total: $0.00 CAD
KPV 10mg
$50.00 CAD
KPV is the C-terminal tripeptide fragment of alpha-MSH (Lys-Pro-Val), investigated in research settings for its role in inflammatory signalling — particularly NF-κB and MAPK pathway modulation — and studied in epithelial, mucosal and wound-repair models where the parent hormone’s pigmentary activity is not wanted.
Description
KPV 10mg
KPV is a three-amino-acid peptide (Lys-Pro-Val) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone. Because it lacks the melanocortin receptor-binding region of the parent molecule, research interest centres on its inflammatory-signalling activity independent of pigmentary effects, including studies of NF-κB and MAPK pathway modulation, cytokine expression, and epithelial and mucosal barrier models.
KPV is also the fourth component of the KLOW blend, alongside GHK-Cu, BPC-157 and TB-500, and is supplied here as a standalone vial for investigators who want to isolate its contribution.
*Sentient Biogenix products are intended solely for non‑clinical laboratory research. It is not approved by Health Canada, the FDA, or any other regulatory authority, and is not for human or animal consumption, nor for diagnostic, therapeutic, or clinical use.
What others are saying
There are no contributions yet.